Wednesday, April 18, 20185:00 PM - 8:00 PM

Please join us on Wednesday, April 18, 2018 for a Healthcare Panel presentation and networking event at the INOVA Personalized Health Conference Center.

Cocktails and hors d'oeuvres will be provided.

American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the stimulation of gamma delta T cells for treating solid tumors in epithelial cancers. U.S. Patent No: 9,914,938 dated March 13, 2018 further consolidates AGT’s intellectual property position surrounding its novel gene therapy platform. The patent describes AGT’s unique lentivirus vector approach to modify tumors for potent activation of naturally-occurring T cells in the immune system providing a highly-effective immune response and destruction of tumors.

In the second financing round announced in one day for an immunometabolism startup, Johns Hopkins spinout Dracen Pharmaceuticals just wrapped up a $36 million investment deal from Deerfield.

The $1.3 trillion fiscal 2018 funding package sent to President Trump early Friday includes big boosts for almost all of the major federal agencies, thanks to a broader two-year budget deal increasing spending caps that President Trump signed last month. 

New York-based investment firm Deerfield Management is leading a $40 million Series A funding round for Baltimore's Dracen Pharmaceuticals Inc.

Novavax may be years away from a potential approval of its RSV vaccine, but on the company's recent year-end conference call, executives talked up the candidate's commercial appeal and the steps they're taking now to prepare for a possible rollout. 

On Wednesday, the Department of Health and Human Services announced that Secretary Alex Azar will name Robert R. Redfield, M.D., as the 18th Director of the Centers for Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease Registry.

Alexandria Real Estate Equities, Inc. (NYSE:  ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced that its board of directors has appointed Jennifer J. Banks and Larry J. Diamond as co-chief operating officers, effective April 23, 2018. Ms. Banks will assume additional responsibilities related to leading the company's risk management operations and will continue as general counsel and corporate secretary. Mr. Diamond will assume a national role overseeing the company's real estate property operations and will continue as regional market director of Maryland.

Alexandria Real Estate Equities Inc, a real estate investment trust focused on collaborative life science and technology campuses in AAA innovation cluster locations, has named Jennifer J. Banks and Larry J. Diamonds as co-chief operating officers. Their appointments become effective April 23, 2018. Banks joined Alexandria in 2002 and has served as the company’s general counsel since 2008 while Diamond joined the company in 1998 to open a regional office in Alexandria’s Maryland life science cluster.

In some ways Martine Rothblatt, the founder and chairwoman of United Therapeutics, a Maryland-based biotechnology company, and James Park, the CEO and co-founder of consumer fitness company Fitbit, are unusual health care leaders and entrepreneurs. Both came from outside the industry—Rothblatt previously created SiriusXM radio, among other things; meanwhile the inspiration for Park’s popular family of wearable devices was the Nintendo Wii— and neither set out steeped in the regulatory arts of American healthcare.

The Maryland state Senate signed off on $5.6 billion in tax incentives to lure Amazon.com Inc. to Montgomery County on Monday night.

Elizabeth M. Jaffee, MD, will become president of American Association for Cancer Research next month.

Jaffee is deputy director of Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, as well as associate director of Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.

Investors got big returns on the initial sale and could see millions more over the coming years, as Harpoon's device continues on the path to U.S. regulatory approval.

Tampa Bay Lightning owner and developer Jeff Vinik is investing $12 million in Dreamit, an early-stage venture fund and startup accelerator with offices in New York, Philadelphia and — in the foreseeable future — Tampa.

Do you find it nearly impossible to resist the opportunity to devour a cupcake, brownie, or doughnut? You’re not alone. Most of us jump at the chance to satisfy our sweet tooth, even though we know it isn’t good for us. Too many people, however, take an all-or-nothing approach when it comes to junk food, which can make it hard to quit. You don’t have to stop eating sugar completely, but eating less of it could improve and even save your life.

If you’ve been to the hospital recently, you’ve probably noticed that the hospital relies on nurses in order to keep everything running smoothly. In fact, according to the United States Bureau of Labor Statistics, there are over 3.1 million nurses in the United States alone.

This spring, the National Institutes of Health will start recruiting participants for one of the most ambitious medical projects ever envisioned.

Tweeting has long posed a dilemma for scientists. There’s abundant evidence that widely sharing a research finding in just one or two simple sentences greatly increases its use and effectiveness.

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

Proscia Inc., creators of AI-powered digital pathology software, today announced it has signed a first-of-its-kind agreement with one of the largest dermatopathology labs in the country, signaling Proscia’s entrance into the dermatopathology market and ushering in a new era of digital and computational pathology applied to dermatology.

Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

Healthwise and GetWellNetwork® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over 600 Healthwise patient education videos to its current suite of patient experience technologies that deliver Precision Engagement™ across the care continuum.

Scheer Partners, the leading provider of fully integrated commercial real estate services in the Washington and Baltimore metropolitan areas, announced today that it has negotiated on behalf of Supernus Pharmaceuticals, Inc., a 118,000-square-foot headquarters lease at 700 Quince Orchard Road, a building owned by the Rock Creek Fund.

Freeman Hrabowski III, the university president and most notable dreamer at Maryland Baltimore County, didn’t close his eyes until 6 a.m. Saturday. He had too many text messages to answer, too many calls to take, too many voice mails to retrieve. He had too many people to hug, too many whys and hows to try to explain, too many Friday night thrills to relive.

ExeGi Pharma LLC, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has launched Visbiome® Vet, a new high potency probiotic for use in dogs to help support normal inflammatory responses in the gastrointestinal (GI) tract and to help normalize gut health.  

At halftime, with players locked in a surprising tie with the top-ranked men’s basketball team in the country, the Twitter feed of the University of Maryland-Baltimore County’s athletic department seized the spotlight to make a sales pitch.

I was enjoying a late dinner with friends at Peter Luger Steak House in Brooklyn, N.Y. — the sizzling plates of porterhouse in full command of my attention — when the familiar name began bubbling out of lips at surrounding tables.

The University of Maryland, Baltimore County woke up on Friday as just another small basketball program looking forward to a run against a No. 1 seed in the NCAA tournament.

The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.

Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.

Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.

Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.

Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.

Novavax CEO Stanley Erck said he believes the last quarter was "the most significant in Novavax corporate history."

The reason? Vaccines, specifically clinical results from the Gaithersburg company's two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.